Biohaven Pharmaceutical Holding Company Ltd

(NYSE:BHVN)

Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Date/Time Type Description Signal Details
2023-05-12 21:12 ESTNewsBiohaven Non-GAAP EPS of -$0.98N/A
2023-03-24 07:34 ESTNewsBiohaven Non-GAAP EPS of -$1.27 beats by $0.01N/A
2023-03-22 08:38 ESTNewsBiohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfrontN/A
2023-03-10 05:36 ESTNewsBiohaven: Spun And Done - Time To ExitN/A
2023-02-21 22:11 ESTNewsBiohaven's spinal muscular atrophy therapy gets FDA fast track statusN/A
2023-01-04 17:02 ESTNewsBiohaven initiated at overweight at JP Morgan on neurological targetsN/A
2022-12-08 04:49 ESTNewsBiohaven Ltd: Assessing The SpinoffN/A
2022-11-09 21:19 ESTNewsBiohaven Non-GAAP EPS of -$1.25N/A
2022-10-21 04:41 ESTNewsBiohaven prices upsized 25M of stock offering at $10.50/shareN/A
2022-10-18 16:23 ESTNewsBiohaven stock falls 5% after the bell on 20M share offeringN/A
2022-10-07 13:52 ESTNewsBiotech in recovery; but Piper Sandler cites negative fund flowsN/A
2022-10-07 13:49 ESTNewsM&A may be a tailwind for biotech sector into end of year, analyst saysN/A
2022-10-07 13:40 ESTNews'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potentialN/A
2022-10-06 23:49 ESTNewsBiohaven Stub May Provide An Interesting Setup For InvestorsN/A
2022-09-29 23:19 ESTNewsBiohaven says ALS candidate failed in key trialN/A
2022-09-28 00:37 ESTNewsPfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3N/A
2022-09-19 19:50 ESTNewsBiohaven announces timeline for spinoffN/A
2022-08-17 15:12 ESTNewsBiohaven: Non-Standard Merger Consideration Makes This A BuyN/A
2022-08-16 05:06 ESTNewsSoros Fund Management takes new stakes in GCP, Biohaven, TeslaN/A
2022-08-05 15:33 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6MN/A
2022-07-07 09:59 ESTNewsBiohaven begins enrolling in late-stage trial of spinal muscular atrophy therapyN/A
2022-06-15 23:08 ESTNewsBiohaven Deal: Pfizer Gives Away A FreerollN/A
2022-06-01 11:56 ESTNewsFederal Trade Commission to hold pharma merger and antitrust workshopN/A
2022-05-23 14:53 ESTNewsBiohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progressionN/A
2022-05-23 14:53 ESTNewsBiohaven gets FDA review for nasal spray zavegepant to treat migraineN/A
2022-05-11 01:00 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14MN/A
2022-05-11 01:00 ESTNewsPfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%N/A
2022-05-06 21:00 ESTNewsBiohaven Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-27 19:21 ESTNewsPfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraineN/A
2022-04-14 05:28 ESTNewsBiohaven Pharmaceutical: Recent Growth Will ContinueN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47MN/A
2022-02-26 00:18 ESTNewsBiohaven in licensing pact with Bristol Myers; to acquire Channel BiosciencesN/A
2022-02-26 00:18 ESTNewsPfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatmentN/A
2022-02-26 00:18 ESTNewsBiohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-02-26 00:17 ESTNewsBiohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-25 05:15 ESTNewsBiohaven Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-22 19:32 ESTNewsBiohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitisN/A
2022-02-15 01:21 ESTNewsPfizer/ Biohaven announce late-stage migraine trial met main goals in Asia PacificN/A
2022-02-01 23:30 ESTNewsNew thematic psychedelic ETF hits the marketN/A
2022-01-28 21:24 ESTNewsAurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen newsN/A
2022-01-18 18:11 ESTNewsBiohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapiesN/A
2022-01-14 05:01 ESTNewsAurinia Pharmaceuticals reverses decline after report on potential M&A interestN/A
2022-01-10 16:33 ESTNewsBiohaven forms research collaboration to advance TRPM3 antagonists for pain managementN/A
2022-01-06 09:41 ESTNewsBiohaven reports preliminary Q4 Nurtec ODT revenue of $190MN/A
2021-12-07 06:52 ESTNewsBiohaven names Vlad Coric as Chairman, appoints new CFON/A
2021-12-06 12:13 ESTNewsBiohaven says pivotal study for intranasal migraine therapy met main goalsN/A
2021-12-06 12:13 ESTNewsBiohaven names new CEO, CFON/A
2021-11-18 11:13 ESTNewsBiohaven, Artizan to work on Parkinson's drug discovery programN/A
2021-11-17 13:22 ESTNewsBiohaven's migraine med Nurtec approved in KuwaitN/A
2021-11-10 03:44 ESTNewsPfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B dealN/A

About Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

BHVN Quotes by TradingView

See Advanced Chart

General

  • Name Biohaven Pharmaceutical Holding Company Ltd
  • Symbol BHVN
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 825
  • Fiscal Year EndDecember
  • IPO Date2017-05-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.biohavenpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 71.25
  • Price/Book (Most Recent Quarter) 31.82
  • Enterprise Value Revenue 73.75
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$10.49
  • Next Year EPS Estimate -$5.57
  • Next Quarter EPS Estimate -$2.73
  • Operating Margin -1014%
  • Return on Assets -78%
  • Revenue 63.63 million
  • Earnings Per Share -$9.14
  • Revenue Per Share $1.08
  • Gross Profit 45.93 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 4.42 billion
  • EBITDA -356321504
  • Analyst Target Price $102.09
  • Book Value Per Share $2.09
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 54.37 million
  • % Held by Insiders 1379%
  • % Held by Institutions 117.55%
  • Shares Short 5.76 million
  • Shares Short Prior Month 5.98 million
  • Short Ratio 11.39
  • Short % of Float 13%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.08
  • 52 Week High $100.77
  • 52 Week Low $28.26
  • 50 Day Moving Average 82.8
  • 200 Day Moving Average 80.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$2.69-$2.56-4.98%
2020-09-302020-11-09$17.66 million-$2.67-$2.866.58%
2020-06-302020-08-10$9.7 million-$2.55-$2.8410.27%
2020-03-312020-05-07$1.15 million-$2.39-$2.462.94%
2019-12-312020-02-25$N/A-$2.85-$1.91-49.31%
2019-09-302019-11-01$N/A-$2.04-$1.57-30.24%
2019-06-302019-08-08$N/A-$4.67-$2.09-123.21%
2019-03-312019-05-07$N/A-$1.41-$1.505.94%
2018-12-312019-02-28$N/A-$1.33-$1.21-10.12%
2018-09-302018-11-14$N/A-$1.53-$1.08-42.33%
2018-06-302018-08-14$N/A-$1.01-$1.053.68%
2018-03-312018-05-15$N/A-$2.32-$1.17-98.29%
2017-12-312018-03-06$N/A-$0.75-$1.3544.34%
2017-09-302017-11-14$N/A-$1.19-$1.243.78%
2017-06-302017-08-14$N/A-$1.78-$0.62-185.94%
2017-03-312017-06-16$N/A-$1.74-$1.45-20%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:

Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:

Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-192.58.19CALL0 00TRUE00
2025-12-1955.69CALL0 700469.88TRUE00
2025-12-197.53.92CALL1 5560TRUE0.220.06
2025-12-19101.95CALL118 4362182.31TRUE-0.05-0.03
2025-12-1912.50.9CALL418 10419216.63FALSE0.10.13
2025-12-19150.42CALL89 3840225.75FALSE-0.03-0.07
2025-12-1917.50.17CALL815 8137237.97FALSE-0.03-0.15
2025-12-19200.1CALL6 9181258.28FALSE00
2025-12-1922.50.15CALL0 589461.54FALSE00
2025-12-19250.05CALL0 503504.44FALSE00
2025-12-1927.50.05CALL0 622392.4FALSE00
2025-12-19300.09CALL3 12845384.79FALSE0.090
2025-12-1932.50.02CALL0 118604.54FALSE00
2025-12-19350.05CALL0 1811495.34FALSE00
2025-12-19400.08CALL0 5401664.2FALSE00
2025-12-1942.50.01CALL0 1731699.2FALSE00
2025-12-19450.71CALL0 256718.56FALSE00
2025-12-1947.51.57CALL0 4736.63FALSE00
2025-12-19500.05CALL0 1663541.92FALSE00
2025-12-1952.50.75CALL0 34769.52FALSE00
2025-12-19551.05CALL0 24784.56FALSE00
2025-12-1957.50.8CALL0 16733.53FALSE00
2025-12-19600.24CALL0 49706.93FALSE00
2025-12-1962.50.2CALL0 2696.19FALSE00
2025-12-19650.25CALL0 38751.54FALSE00
2025-12-19700CALL0 1671.79FALSE00
2025-12-19750.55CALL0 5721.8FALSE00
2025-12-19800.15CALL0 5708.03FALSE00
2025-12-192.50.1PUT0 100639.62FALSE00
2025-12-1950.03PUT0 304363.16FALSE00
2025-12-197.50.07PUT21 4422218.77FALSE0.020.4
2025-12-19100.63PUT2070 3932228.42FALSE0.130.26
2025-12-1912.51.89PUT0 5457205.85TRUE00
2025-12-19154PUT0 2110260.79TRUE00
2025-12-1917.56.95PUT0 449313.82TRUE00
2025-12-192010PUT0 240TRUE00
2025-12-1922.513.7PUT0 100TRUE00
2025-12-192517.25PUT0 32355.86TRUE00
2025-12-1927.515.3PUT0 0388.09TRUE00
2025-12-193021.66PUT0 2340.15TRUE00
2025-12-1932.50PUT0 0363.46TRUE00
2025-12-193520.35PUT0 0384.82TRUE00
2025-12-194026.49PUT0 0422.83TRUE00
2025-12-1942.50PUT0 0526.84TRUE00
2025-12-19450PUT0 0544.26TRUE00
2025-12-1947.50PUT0 0560.6TRUE00
2025-12-19500PUT0 0575.99TRUE00
2025-12-1952.50PUT0 0553.73TRUE00
2025-12-19550PUT0 0604.29TRUE00
2025-12-1957.50PUT0 0617.38TRUE00
2025-12-19600PUT0 0629.84TRUE00
2025-12-1962.50PUT0 0641.73TRUE00
2025-12-19650PUT0 0653.11TRUE00
2025-12-19700PUT0 0674.48TRUE00
2025-12-19750PUT0 0694.23TRUE00
2025-12-19800PUT0 0672.83TRUE00
2026-01-162.50CALL0 0279.15TRUE00
2026-01-1656.65CALL0 400TRUE00
2026-01-167.54.32CALL7 424131.67TRUE0.110.03
2026-01-16102.7CALL62 2345139.66TRUE0.050.02
2026-01-1612.51.65CALL333 8244143.67FALSE0.10.06
2026-01-16151.01CALL119 3079146.63FALSE00
2026-01-1617.50.79CALL692 2013163.24FALSE0.190.32
2026-01-16200.39CALL10 4439150.42FALSE0.040.11
2026-01-1622.50.22CALL0 247148.36FALSE00
2026-01-16250.05CALL0 5398182.54FALSE00
2026-01-1627.50.12CALL0 16227.13FALSE00
2026-01-16300.05CALL0 685210.46FALSE00
2026-01-1632.51.76CALL0 14253.51FALSE00
2026-01-16350.1CALL1 815183.91FALSE0.10
2026-01-1637.50.05CALL0 32275.09FALSE00
2026-01-16400.05CALL1 8412181.31FALSE0.050
2026-01-1642.51CALL0 45293.31FALSE00
2026-01-16450.05CALL0 186301.44FALSE00
2026-01-1647.50.95CALL0 199309.04FALSE00
2026-01-16500.01CALL1 354172.46FALSE0.010
2026-01-1652.51.05CALL0 55322.86FALSE00
2026-01-16550.3CALL0 31329.19FALSE00
2026-01-1657.50.45CALL0 3271.21FALSE00
2026-01-16600.34CALL0 98276.37FALSE00
2026-01-16650.4CALL0 3357.62FALSE00
2026-01-162.50.06PUT0 13269.16FALSE00
2026-01-1650.05PUT0 3304175.66FALSE00
2026-01-167.50.34PUT7 4970143.42FALSE-0.01-0.03
2026-01-16101.18PUT1240 5808143.29FALSE0.030.03
2026-01-1612.52.55PUT135 3541141.54TRUE-0.13-0.05
2026-01-16154.96PUT0 1000159.06TRUE00
2026-01-1617.58.14PUT0 90178.89TRUE00
2026-01-162010.3PUT0 613170.63TRUE00
2026-01-1622.514.48PUT0 131140.84TRUE00
2026-01-162516.4PUT0 9166.07TRUE00
2026-01-1627.519.11PUT0 0171.61TRUE00
2026-01-163015.8PUT0 0184.55TRUE00
2026-01-1632.50PUT0 0196.28TRUE00
2026-01-16350PUT0 0194.87TRUE00
2026-01-1637.524.3PUT0 00TRUE00
2026-01-164025PUT0 0213.53TRUE00
2026-01-1642.50PUT0 0204.08TRUE00
2026-01-16450PUT0 0211.77TRUE00
2026-01-1647.50PUT0 0250.28TRUE00
2026-01-16500PUT0 0257.42TRUE00
2026-01-1652.50PUT0 0232.29TRUE00
2026-01-16550PUT0 0270.61TRUE00
2026-01-1657.50PUT0 0276.74TRUE00
2026-01-16600PUT0 00TRUE00
2026-01-16650PUT0 0293.6TRUE00
2026-04-172.56.5CALL0 360TRUE00
2026-04-1754.38CALL0 49116.97TRUE00
2026-04-177.55.17CALL21 337122.31TRUE0.370.08
2026-04-17103.84CALL10 625120.26TRUE-0.21-0.05
2026-04-1712.53.11CALL11 436128.67FALSE-0.09-0.03
2026-04-17152.34CALL35 2375125.51FALSE-0.11-0.04
2026-04-1717.52CALL0 929128.26FALSE00
2026-04-17202.15CALL1 120125.85FALSE0.70.48
2026-04-1722.51.2CALL3 785127.72FALSE00
2026-04-17251CALL1 112129.08FALSE00
2026-04-1727.50.8CALL2 238128.19FALSE0.80
2026-04-17300.55CALL0 219131.8FALSE00
2026-04-1732.53.3CALL0 174132.92FALSE00
2026-04-17350.55CALL0 1014126.23FALSE00
2026-04-172.50.25PUT5 20201.28FALSE0.250
2026-04-1750.55PUT5 142149.45FALSE0.550
2026-04-177.51.6PUT0 468132.69FALSE00
2026-04-17102.38PUT2 168128.44FALSE2.380
2026-04-1712.53.93PUT0 135127.12TRUE00
2026-04-17155.7PUT1 141127.4TRUE5.70
2026-04-1717.58.57PUT0 31126.71TRUE00
2026-04-172011.7PUT0 4122.78TRUE00
2026-04-1722.511.1PUT0 6145.74TRUE00
2026-04-17250PUT0 0148.71TRUE00
2026-04-1727.516.4PUT0 20149.78TRUE00
2026-04-173017.86PUT0 1158.29TRUE00
2026-04-1732.518.8PUT0 28163.72TRUE00
2026-04-173523.7PUT0 41166.06TRUE00
2026-07-172.50CALL0 090.64TRUE00
2026-07-1755.7CALL0 2130.42TRUE00
2026-07-177.54.8CALL0 20128.45TRUE00
2026-07-17104.93CALL40 49127.4TRUE4.930
2026-07-1712.54.1CALL3 1337126.7FALSE-0.12-0.03
2026-07-17153.46CALL8 122126.59FALSE3.460
2026-07-1717.52.89CALL2 64124.82FALSE-0.21-0.07
2026-07-17202.1CALL0 1119.73FALSE00
2026-07-172.50PUT0 0144.99FALSE00
2026-07-1750PUT0 0112.68FALSE00
2026-07-177.51.9PUT1 16132.03FALSE1.90
2026-07-17103.03PUT2 50121.29FALSE-0.15-0.05
2026-07-1712.54.83PUT0 1124.07TRUE00
2026-07-17157PUT0 63124.88TRUE00
2026-07-1717.50PUT0 0126.07TRUE00
2026-07-17200PUT0 0118.64TRUE00
2026-12-182.58.5CALL0 3476.63TRUE00
2026-12-1857.8CALL0 30102.61TRUE00
2026-12-187.54.35CALL0 8080.76TRUE00
2026-12-18105.5CALL0 252122.91TRUE00
2026-12-1812.54.7CALL0 66106.37FALSE00
2026-12-18153.73CALL0 569115.25FALSE00
2026-12-1817.52.61CALL0 11112.61FALSE00
2026-12-18203.27CALL200 672111.52FALSE3.270
2026-12-1822.50CALL0 1109.28FALSE00
2026-12-18252.57CALL200 24110.05FALSE2.570
2026-12-1827.50CALL0 0109.04FALSE00
2026-12-18302.3CALL0 991.12FALSE00
2026-12-1832.51.5CALL0 1115.87FALSE00
2026-12-18351.45CALL0 54119.72FALSE00
2026-12-1837.50CALL0 0122.09FALSE00
2026-12-18401.25CALL0 4125.31FALSE00
2026-12-1842.51.25CALL0 1128.27FALSE00
2026-12-18451.15CALL0 37131.02FALSE00
2026-12-1847.50CALL0 2132.43FALSE00
2026-12-18501CALL0 11134.83FALSE00
2026-12-1852.52.75CALL0 9137.08FALSE00
2026-12-18553.33CALL0 2139.21FALSE00
2026-12-1857.50CALL0 0141.21FALSE00
2026-12-18601.05CALL0 15143.12FALSE00
2026-12-18651.95CALL0 10146.65FALSE00
2026-12-182.50.4PUT0 65136.85FALSE00
2026-12-1850.75PUT0 2128.82FALSE00
2026-12-187.52.55PUT0 16490.56FALSE00
2026-12-18104.35PUT0 26889.82FALSE00
2026-12-1812.55.5PUT0 305103.1TRUE00
2026-12-18158.52PUT0 188118.69TRUE00
2026-12-1817.510.55PUT0 1116.01TRUE00
2026-12-18200PUT0 0116.06TRUE00
2026-12-1822.50PUT0 22114.65TRUE00
2026-12-182516PUT0 8119.76TRUE00
2026-12-1827.50PUT0 0120.71TRUE00
2026-12-183022.56PUT0 330120.91TRUE00
2026-12-1832.50PUT0 0120.31TRUE00
2026-12-18350PUT0 5123.88TRUE00
2026-12-1837.50PUT0 0123.54TRUE00
2026-12-184032.3PUT0 30121.41TRUE00
2026-12-1842.50PUT0 0125.17TRUE00
2026-12-18450PUT0 0120.75TRUE00
2026-12-1847.50PUT0 0119.71TRUE00
2026-12-18500PUT0 0124.32TRUE00
2026-12-1852.50PUT0 0131.59TRUE00
2026-12-18550PUT0 0123.85TRUE00
2026-12-1857.50PUT0 0121.38TRUE00
2026-12-18600PUT0 0109.55TRUE00
2026-12-18650PUT0 0120.21TRUE00
2027-01-152.59.42CALL0 5486.44TRUE00
2027-01-1556.07CALL0 59108.85TRUE00
2027-01-157.56CALL0 45116.04TRUE00
2027-01-15106CALL1 759121.07TRUE60
2027-01-1512.55CALL0 88113.1FALSE00
2027-01-15154.39CALL128 3163112.38FALSE-0.01-0
2027-01-1517.52.88CALL0 83110FALSE00
2027-01-15202.4CALL0 98108.5FALSE00
2027-01-1522.50CALL0 3109.37FALSE00
2027-01-15252.98CALL113 214114.51FALSE0.10.03
2027-01-1527.52.1CALL0 12110.8FALSE00
2027-01-15301.74CALL0 2601109.6FALSE00
2027-01-1532.52.65CALL0 1112.66FALSE00
2027-01-15351.1CALL0 4115.29FALSE00
2027-01-1537.50CALL0 0117.59FALSE00
2027-01-15401.2CALL0 135120.69FALSE00
2027-01-1542.51.46CALL0 50122.44FALSE00
2027-01-15451.42CALL0 8125.09FALSE00
2027-01-1547.50CALL0 0126.45FALSE00
2027-01-15501.25CALL0 14128.76FALSE00
2027-01-1552.50CALL0 0130.93FALSE00
2027-01-15551.4CALL0 1131.84FALSE00
2027-01-1557.50.05CALL0 1133.77FALSE00
2027-01-15602.05CALL0 6134.46FALSE00
2027-01-15651CALL0 10115.74FALSE00
2027-01-152.50.5PUT0 12137.55FALSE00
2027-01-1551.2PUT0 2140.63FALSE00
2027-01-157.52.58PUT0 42111.62FALSE00
2027-01-15104.62PUT0 8112.61FALSE00
2027-01-1512.55.54PUT0 3114.06TRUE00
2027-01-15158.3PUT0 229113.83TRUE00
2027-01-1517.50PUT0 12112.43TRUE00
2027-01-152013.32PUT0 15110.42TRUE00
2027-01-1522.514.9PUT0 3112.28TRUE00
2027-01-15250PUT0 8116.23TRUE00
2027-01-1527.50PUT0 0117.22TRUE00
2027-01-15300PUT0 4117.41TRUE00
2027-01-1532.50PUT0 0116.91TRUE00
2027-01-153522PUT0 2120.43TRUE00
2027-01-1537.524.85PUT0 30120.16TRUE00
2027-01-15400PUT0 10118.14TRUE00
2027-01-1542.50PUT0 1115.5TRUE00
2027-01-15450PUT0 0124.05TRUE00
2027-01-1547.50PUT0 0122.2TRUE00
2027-01-15500PUT0 0125.26TRUE00
2027-01-1552.50PUT0 0128.18TRUE00
2027-01-15550PUT0 0123.85TRUE00
2027-01-1557.50PUT0 0126.49TRUE00
2027-01-15600PUT0 0117.07TRUE00
2027-01-15650PUT0 0121.76TRUE00
2028-01-212.57.83CALL0 43956.83TRUE00
2028-01-2157.82CALL0 9080.26TRUE00
2028-01-217.57.08CALL0 48593.58TRUE00
2028-01-21107CALL0 62296.46TRUE00
2028-01-2112.54.96CALL0 3792.97FALSE00
2028-01-21153.98CALL0 194107.8FALSE00
2028-01-2117.56.4CALL0 18106.84FALSE00
2028-01-21203.4CALL0 108102.64FALSE00
2028-01-2122.54CALL0 699.67FALSE00
2028-01-21254CALL0 55100.14FALSE00
2028-01-2127.54.96CALL0 25100.12FALSE00
2028-01-21303CALL0 1499.72FALSE00
2028-01-2132.50CALL0 098.99FALSE00
2028-01-21351.87CALL0 31101.73FALSE00
2028-01-212.50.8PUT0 11130.79FALSE00
2028-01-2150PUT0 0285.74FALSE00
2028-01-217.53.4PUT0 20125.34FALSE00
2028-01-21104.65PUT0 779114.1FALSE00
2028-01-2112.58.05PUT0 0102.86TRUE00
2028-01-21159.88PUT0 5104.63TRUE00
2028-01-2117.512.42PUT0 1104.83TRUE00
2028-01-212011.87PUT0 0104.01TRUE00
2028-01-2122.50PUT0 0102.49TRUE00
2028-01-21250PUT0 0100.23TRUE00
2028-01-2127.50PUT0 0105.3TRUE00
2028-01-21300PUT0 0102.09TRUE00
2028-01-2132.50PUT0 0106.31TRUE00
2028-01-213527.45PUT0 10102.22TRUE00

Latest BHVN Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST40$143.84
Jun 13, 2022 7:59 PM EST9$143.84
Jun 13, 2022 7:59 PM EST8$143.87
Jun 13, 2022 7:59 PM EST100$143.87
Jun 13, 2022 7:59 PM EST3$143.83

Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm
2019-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm
2019-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm
2020-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm
2020-04-16DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm
2019-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-03-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-04-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm
2019-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2019-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2019-06-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm
2019-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2020-01-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-01-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm
2020-03-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm
2020-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-123/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-10-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-11-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-02-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm
2018-12-10S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm
2018-12-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm
2018-12-12S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm
2018-12-14424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm
2019-06-17S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm
2019-06-18424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm
2019-06-20424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm
2019-06-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm
2020-01-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm
2020-01-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm
2020-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm
2018-12-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm
2019-04-11DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm
2019-04-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm
2019-05-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm
2019-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm
2019-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm
2019-08-09S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-09-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm
2019-11-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm
2019-12-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2019-12-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm
2020-03-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm
2020-06-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm
2020-08-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm
2018-12-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1379%
Institutional Ownership: 11755%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-10-15Elyse StockChief Medical OfficerSell800.0045.0136,008.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-18Elyse StockChief Medical OfficerSell17,700.0045.07797,749.620.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-02-04ERIC AGUIARDirectorSell17,609.0042.54749,086.860.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorSell10,000.0045.00450,000.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-11-20ERIC AGUIARDirectorSell6,729.0052.20351,234.290.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-22ERIC AGUIARDirectorSell1,250.0055.2469,050.000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-09ERIC AGUIARDirectorSell4,072.0055.11224,410.770.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-16ERIC AGUIARDirectorSell3,537.0055.13194,984.550.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-01-10John TiltonChief Commercial OfficerSell10,500.0037.67395,535.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-12John TiltonChief Commercial OfficerSell10,000.0050.11501,100.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-02-21JULIA P GREGORYDirectorSell12,000.0043.56522,720.000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorSell12,000.0054.75656,956.800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsSell3,935.0053.03208,665.180.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsSell21,065.0053.041,117,205.450.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-01-09ERIC AGUIARDirectorSell30,000.0056.391,691,700.000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2019-02-04ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11ERIC AGUIARDirectorBuy10,000.0025.51255,100.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-03-12John TiltonChief Commercial OfficerBuy10,000.009.2992,900.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-06-26JOHN W CHILDSDirectorBuy10,000.0040.37403,700.0010,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-03-26Declan DooganDirectorSell5,824.0053.72312,865.281,014,827.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-22Declan DooganDirectorSell5,351.0053.66287,134.661,020,651.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-01Declan DooganDirectorSell50,000.0047.192,359,500.001,026,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-01-10John TiltonChief Commercial OfficerBuy10,500.009.2997,545.0010,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-22JOHN W CHILDSDirectorBuy107,500.009.29998,675.00107,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-03-01Declan DooganDirectorSell595.0045.4127,018.951,076,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-27Declan DooganDirectorSell23,384.0045.711,068,882.641,076,597.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Vlad CoricChief Executive OfficerBuy10,950.0010,950.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-02-25Declan DooganDirectorSell13,943.0045.49634,267.071,099,981.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-19Declan DooganDirectorSell1,400.0045.5163,714.001,113,924.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-15Declan DooganDirectorSell678.0045.4230,794.761,115,324.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-13Declan DooganDirectorSell6,158.0044.24272,429.921,116,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-12Declan DooganDirectorSell33,842.0044.321,499,877.441,122,160.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2018-12-03Declan DooganDirectorSell40,000.0041.951,678,000.001,156,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-02-21JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22JULIA P GREGORYDirectorBuy12,000.0023.63283,560.0012,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-18John TiltonCCO-Rare & Neurologic DisorderBuy1,250.001,250.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2020-01-08ERIC AGUIARDirectorBuy1,250.0055.9169,887.501,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-22ERIC AGUIARDirectorSell150.0058.868,828.601,250.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtBuy125,000.000.6176,250.00125,341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-12Elyse StockChief Medical OfficerSell15,925.0064.891,033,347.7713,234.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtBuy986.000.61601.461,327.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-11James EngelhartChief Financial OfficerSell4,847.0063.19306,286.2913,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell200.0058.0011,599.001,400.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy11,453.009.29106,398.3715,975.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22ERIC AGUIARDirectorSell671.0056.9938,243.181,600.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell59,914.0075.254,508,822.081,741.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell1,300.0077.70101,005.061,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2019-02-04ERIC AGUIARDirectorBuy7,609.0020.79158,191.1117,609.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-10-18Elyse StockChief Medical OfficerBuy17,700.0010.82191,514.0017,700.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2020-06-11James EngelhartChief Financial OfficerSell5,972.0062.07370,697.5718,322.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12Elyse StockChief Medical OfficerSell11,390.0065.80749,497.311,844.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-06-26Vlad CoricChief Executive OfficerBuy5,000.0040.22201,100.0019,130.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2020-01-22ERIC AGUIARDirectorBuy771.0032.4224,995.822,021.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-11-21Kimberly GentileSVP, Clinical OperationsBuy21,065.000.6112,849.6521,065.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell5,261.0075.62397,843.6621,878.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy20,716.0020.79430,685.6422,560.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0055.9927,995.502,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-06-27Robert BermanChief Medical OfficerBuy2,500.0042.30105,750.00240,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2020-06-11James EngelhartChief Financial OfficerBuy19,772.009.29183,681.8824,294.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-04-07JOHN W CHILDSDirectorSell14,734.0033.26490,119.142,476,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-08-11JOHN W CHILDSDirectorBuy2,600.0060.32156,823.942,479,538.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-08-11JOHN W CHILDSDirectorBuy7,271.0061.28445,567.612,486,809.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-04-07JOHN W CHILDSDirectorSell93,268.0032.923,070,130.742,491,672.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2019-06-27James EngelhartChief Financial OfficerBuy2,500.0043.05107,625.002,500.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2020-08-11JOHN W CHILDSDirectorBuy15,129.0061.87936,093.262,501,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-11JOHN W CHILDSDirectorBuy6,678.0059.00393,983.972,508,616.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-21JOHN W CHILDSDirectorBuy3,322.0059.25196,828.502,511,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-23Gregory BaileyDirectorSell212.0079.9416,948.002,545,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-23Gregory BaileyDirectorSell10,191.0078.89803,918.052,545,870.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell3,100.0079.88247,632.032,556,061.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22Gregory BaileyDirectorSell21,466.0079.411,704,720.242,559,161.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-19Gregory BaileyDirectorSell4,554.0078.98359,655.342,580,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-03-25Gregory BaileyDirectorBuy107,500.009.29998,675.002,582,601.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2020-04-07JOHN W CHILDSDirectorSell10,908.0031.55344,196.492,584,940.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-10-16Gregory BaileyDirectorSell3,748.0078.88295,638.122,585,181.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-08-20Gregory BaileyDirectorBuy5,000.0037.65188,250.002,587,601.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2020-10-12Gregory BaileyDirectorSell6,729.0078.87530,740.452,588,929.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-07-08Gregory BaileyDirectorSell5,991.0075.93454,888.242,595,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-04-07JOHN W CHILDSDirectorSell81,090.0030.542,476,585.912,595,848.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-07-08Gregory BaileyDirectorSell44,009.0075.123,305,876.862,601,649.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-06-24Gregory BaileyDirectorSell2,395.0070.24168,224.802,645,658.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-24Gregory BaileyDirectorSell1,600.0069.29110,864.962,648,053.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell835.0075.1862,779.312,649,653.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23Gregory BaileyDirectorSell63,257.0074.604,719,256.862,650,488.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-04-06JOHN W CHILDSDirectorSell5,341.0031.76169,626.962,676,938.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-04-06JOHN W CHILDSDirectorSell144,659.0031.234,517,309.992,682,279.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-06-23Gregory BaileyDirectorSell24,084.0073.721,775,368.922,713,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsBuy23,500.009.29218,315.0027,139.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-23Gregory BaileyDirectorSell13,467.0072.70979,026.662,737,829.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-22Gregory BaileyDirectorSell49,132.0073.643,618,011.702,751,296.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy24,000.005.60134,400.0027,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-01-22ERIC AGUIARDirectorSell500.0054.9727,485.852,771.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-05Gregory BaileyDirectorBuy212,500.000.61129,625.002,800,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-22Gregory BaileyDirectorSell20,659.0072.911,506,202.242,800,428.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-22Gregory BaileyDirectorSell10,540.0072.01758,961.162,821,087.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell428.0075.2232,193.392,831,627.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell22,584.0073.781,666,267.852,832,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell12,157.0072.93886,618.522,854,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell21,798.0071.981,568,935.032,866,796.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19Gregory BaileyDirectorSell58,238.0070.914,129,854.592,888,594.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-12Elyse StockChief Medical OfficerSell5,300.0064.05339,448.0429,159.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19Gregory BaileyDirectorSell26,814.0070.101,879,792.792,946,832.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy150,000.005.60840,000.002,950,101.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10James EngelhartChief Financial OfficerSell28,821.0066.661,921,135.8129,654.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-19Gregory BaileyDirectorSell22,012.0069.011,519,094.352,973,646.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05Gregory BaileyDirectorBuy37,700.009.29350,233.002,987,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2019-12-18WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy3,000.003,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2020-01-09ERIC AGUIARDirectorBuy30,000.009.29278,700.0030,000.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-06-05Gregory BaileyDirectorBuy20,000.0010.82216,400.003,007,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-05Gregory BaileyDirectorBuy18,000.0028.76517,680.003,025,801.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy1,000.0037.5437,540.003,049.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell4,010.0077.01308,799.273,055.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell55,626.0075.254,185,745.253,119.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-10John TiltonChief Commercial OfficerSell21,364.0066.701,425,036.4831,406.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseBuy30,000.0050.721,521,600.0031,755.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-10John TiltonChief Commercial OfficerSell5,331.0068.57365,528.013,237.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-01-22ERIC AGUIARDirectorBuy1,250.0037.5446,925.003,271.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy17,500.000.6110,675.0033,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Elyse StockChief Medical OfficerBuy3,375.003,375.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell300.0055.9716,791.00341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtSell1,400.0076.05106,467.48341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-19Robert BermanSpecial Projects & Med OvrsghtSell986.0075.0774,015.96341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtSell4,296.0075.05322,431.12341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtSell2,778.0075.29209,144.51341.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-12Elyse StockChief Medical OfficerSell4,351.0063.02274,208.7234,459.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-12-16ERIC AGUIARDirectorBuy3,537.0020.7973,534.233,537.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2020-01-09Kimberly GentileSVP, Clinical OperationsBuy590.0020.7912,266.103,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsSell600.0070.0542,027.483,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsSell24,000.0070.201,684,869.603,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell2,458.0077.42190,300.083,639.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy36,314.000.6122,151.5436,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-02-27Declan DooganDirectorSell1,900.0045.8687,134.00373,913.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18Kimberly GentileSVP, Clinical OperationsBuy3,750.003,750.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-02-27Declan DooganDirectorSell18,270.0045.25826,717.50375,813.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2020-06-12Elyse StockChief Medical OfficerBuy16,250.0032.42526,825.0038,810.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-11-20Kimberly GentileSVP, Clinical OperationsBuy3,935.000.612,400.353,935.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-02-27Declan DooganDirectorSell6,875.0044.17303,668.75394,083.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-26Declan DooganDirectorSell100.0044.814,481.00400,958.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-26Declan DooganDirectorSell20,796.0044.31921,470.76401,058.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-17Kimberly GentileSVP, Clinical OperationsBuy400.005.602,240.004,039.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2019-12-09ERIC AGUIARDirectorBuy4,072.0020.7984,656.884,072.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell53,762.0053.432,872,449.904,129.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-02-25Declan DooganDirectorSell100.0045.744,574.00421,854.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-25Declan DooganDirectorSell20,334.0045.25920,113.50421,954.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-08Kimberly GentileSVP, Clinical OperationsBuy600.005.603,360.004,239.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell15,783.0050.03789,623.49440,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell16,050.0044.97721,768.50442,288.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-10James EngelhartChief Financial OfficerSell300.0068.0720,420.014,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-11James EngelhartChief Financial OfficerSell2,452.0064.85159,015.394,522.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell8,262.0050.02413,265.24455,783.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22Declan DooganDirectorSell5,575.0044.11245,913.25458,338.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-23Robert BermanSpecial Projects & Med OvrsghtBuy4,296.000.612,620.564,637.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell25,955.0050.151,301,643.25464,045.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14Vlad CoricChief Executive OfficerSell16,110.0050.02805,822.20475,000.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10James EngelhartChief Financial OfficerSell24,832.0067.531,676,989.394,822.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13Vlad CoricChief Executive OfficerSell7,883.0050.02394,307.66491,110.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-12Vlad CoricChief Executive OfficerSell26,007.0050.151,304,251.05498,993.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10John TiltonChief Commercial OfficerBuy52,000.009.29483,080.0052,770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell67,450.0052.953,571,349.3557,891.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-10James EngelhartChief Financial OfficerBuy25,000.005.60140,000.0058,475.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-07-08Robert BermanSpecial Projects & Med OvrsghtBuy58,404.000.6135,626.4458,745.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-10-08Kimberly GentileSVP, Clinical OperationsSell15,781.0076.421,205,938.266,097.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18Robert BermanSpecial Projects & Med OvrsghtBuy25,000.005.60140,000.0061,655.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-12-18James EngelhartChief Financial OfficerBuy3,700.006,200.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-18Robert BermanSpecial Projects & Med OvrsghtBuy625.00625.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-06-16Declan DooganDirectorSell300.0069.4220,825.01626,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-16Declan DooganDirectorSell25,208.0068.731,732,457.61626,302.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-12-30Robert BermanSpecial Projects & Med OvrsghtSell3,488.0054.89191,462.25641.00https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-16Declan DooganDirectorSell31,920.0067.902,167,514.83651,510.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-11-20ERIC AGUIARDirectorBuy6,729.0032.42218,154.186,729.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2020-06-16Declan DooganDirectorSell2,572.0066.94172,161.71683,430.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell15,797.0068.101,075,800.98686,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-11James EngelhartChief Financial OfficerSell6,501.0064.31418,057.866,974.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18Charles ConwayChief Scientific OfficerBuy3,000.007,000.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2020-06-15Declan DooganDirectorSell18,703.0067.511,262,557.24701,799.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-11-02WILLIAM A JR JONESCCO-Migraine & Common DiseaseSell24,690.0076.021,876,872.087,065.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-15Declan DooganDirectorSell34,336.0066.052,267,872.20720,502.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15Declan DooganDirectorSell11,164.0065.62732,560.47754,838.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-12Declan DooganDirectorSell25,914.0065.781,704,749.90766,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell2,467.0069.40171,201.91770.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12Declan DooganDirectorSell28,086.0064.791,819,683.51791,916.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-10-15Elyse StockChief Medical OfficerBuy800.0010.828,656.00800.00https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2020-06-12Declan DooganDirectorSell18,400.0063.901,175,767.36820,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12Declan DooganDirectorSell7,600.0062.93478,252.04838,402.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell25,039.0064.571,616,873.39846,002.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10John TiltonChief Commercial OfficerSell22,838.0067.531,542,234.158,568.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-11Declan DooganDirectorSell18,474.0063.791,178,530.36871,041.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell20,043.0062.781,258,207.34889,515.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11Declan DooganDirectorSell16,444.0061.971,018,988.64909,558.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-04-16Declan DooganDirectorSell50,000.0061.923,096,000.00926,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2020-01-08Elyse StockChief Medical OfficerBuy937.0055.9152,387.67937.00https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2019-04-12Declan DooganDirectorSell38,825.0053.922,093,444.00976,002.00https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm